Effects of 90Y-microspheres on liver tumors: comparison of intratumoral injection method and intra-arterial injection method
- PMID: 11079501
Effects of 90Y-microspheres on liver tumors: comparison of intratumoral injection method and intra-arterial injection method
Abstract
Internal radiation therapy using intrahepatic arterial injection of 90Y-labeled glass microspheres (90Y-microspheres) has proven to be a promising therapeutic modality for inoperative liver tumor. Recently, direct intratumoral injection of 90Y-microspheres has been performed with even more encouraging results. The purpose of this study was to compare the treatment efficacy of these 2 methods using 90Y-microspheres.
Methods: Forty-eight male rats, each bearing a hepatic tumor, were divided into 4 groups (12 rats in each group) to evaluate the efficacy of treatment. Group 1 received an intratumoral injection of 37 MBq (1 mCi) 90Y-microspheres. Group 2 received an intratumoral injection of 0.1 mL normal saline as the control group. Group 3 received an intra-arterial injection of 37 MBq (1 mCi) 90Y-microspheres. Group 4 received an intra-arterial injection of 0.1 mL normal saline as the control group. Tumor size was measured by liver sonography before injection as well as at 2 and 4 wk after injection. Survival time was calculated from the day of treatment to 2 mo after treatment by Kaplan-Meier survival analysis. The response rate was evaluated by the change in tumor size and survival time. Fisher's exact, 2-tailed test was used to compare response rates.
Results: In the rats treated by intratumoral injection of 90-Y-microspheres, 83.3% (10/12) showed a good response. In contrast, all 12 rats in the control group showed a poor response. The difference was significant (P < 0.00001). Eighty-three percent (10/12) of the rats survived >60 d after intratumoral injection of 90Y-microspheres, whereas only 25% (3/12) of the control rats survived >60 d. The difference was significant (P = 0.0068). In the rats treated by intra-arterial injection of 90Y-microspheres, 58.3% (7/12) showed a good response to the treatment. All rats in the control group showed a poor response. The difference was significant (P = 0.0023). Sixty-six percent (8/12) of the rats survived >60 d after intra-arterial injection of 90Y-microspheres, whereas only 16.7% (2/12) of the control rats survived >60 d. The difference was significant (P = 0.0385). However, the response rate and survival time between the intratumoral treatment group and the intra-arterial treatment group showed no significant difference (P = 0.3707 and 0.3988, respectively).
Conclusion: Both methods (intratumoral treatment and intraarterial treatment) showed a significantly good response rate and prolonged survival time compared with those of the control groups. However, no significant difference was found in the response rate or survival time between intratumoral treatment and intra-arterial treatment.
Similar articles
-
Intratumoral injection of rhenium-188 microspheres into an animal model of hepatoma.J Nucl Med. 1998 Oct;39(10):1752-7. J Nucl Med. 1998. PMID: 9776282
-
Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres.J Nucl Med. 2000 Oct;41(10):1673-81. J Nucl Med. 2000. PMID: 11037997
-
Hepatic artery injection of Yttrium-90-lipiodol: biodistribution in rats with hepatoma.J Nucl Med. 1996 Feb;37(2):332-5. J Nucl Med. 1996. PMID: 8667072
-
Internal radiation therapy for patients with primary or metastatic hepatic cancer: a review.Cancer. 1998 Nov 1;83(9):1894-907. Cancer. 1998. PMID: 9806647 Review.
-
Spherex (degradable starch microspheres) chemo-occlusion--enhancement of tumor drug concentration and therapeutic efficacy: an overview.Semin Oncol. 1997 Apr;24(2 Suppl 6):S6-100-S6-109. Semin Oncol. 1997. PMID: 9151924 Review.
Cited by
-
Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model.PLoS One. 2017 Aug 22;12(8):e0181944. doi: 10.1371/journal.pone.0181944. eCollection 2017. PLoS One. 2017. PMID: 28829785 Free PMC article.
-
Functional hydrogels for hepatocellular carcinoma: therapy, imaging, and in vitro model.J Nanobiotechnology. 2024 Jul 1;22(1):381. doi: 10.1186/s12951-024-02547-9. J Nanobiotechnology. 2024. PMID: 38951911 Free PMC article. Review.
-
Evaluation of Therapeutic Efficacy and Imaging Capabilities of 153Sm2O3-Loaded Polystyrene Microspheres for Intra-Tumoural Radionuclide Therapy of Liver Cancer Using Sprague-Dawley Rat Model.Pharmaceutics. 2023 Feb 6;15(2):536. doi: 10.3390/pharmaceutics15020536. Pharmaceutics. 2023. PMID: 36839858 Free PMC article.
-
AS30D model of hepatocellular carcinoma: tumorigenicity and preliminary characterization by imaging, histopathology, and immunohistochemistry.Cardiovasc Intervent Radiol. 2013 Feb;36(1):198-203. doi: 10.1007/s00270-012-0466-1. Epub 2012 Aug 25. Cardiovasc Intervent Radiol. 2013. PMID: 22923329 Free PMC article.
-
Biodistribution, Pharmacokinetics and Efficacy of 188Re(I)-Tricarbonyl-Labeled Human Serum Albumin Microspheres in an Orthotopic Hepatoma Rat Model.In Vivo. 2018 May-Jun;32(3):567-573. doi: 10.21873/invivo.11277. In Vivo. 2018. PMID: 29695562 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources